(0.08%) 5 331.75 points
(0.01%) 40 142 points
(0.13%) 18 659 points
(-0.06%) $80.01
(0.53%) $2.64
(1.08%) $2 443.60
(2.77%) $32.13
(0.29%) $1 093.20
(-0.03%) $0.920
(-0.07%) $10.67
(0.01%) $0.787
(-0.32%) $90.68
@ $10.28
Issued: 14 Feb 2024 @ 09:30
Return: 75.58%
Previous signal: Feb 12 - 15:25
Previous signal:
Return: -3.95 %
Live Chart Being Loaded With Signals
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients...
Stats | |
---|---|
Today's Volume | 339 198 |
Average Volume | 407 849 |
Market Cap | 652.02M |
EPS | $0 ( 2024-05-08 ) |
Next earnings date | ( $-1.260 ) 2024-06-11 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.78 |
ATR14 | $0.0310 (0.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-10 | Boxer Capital, Llc | Buy | 1 142 857 | Common Stock |
2024-05-12 | Ra Capital Management, L.p. | Buy | 900 000 | Pre- Funded Warrants (Right to Buy) |
2024-05-10 | Ra Capital Management, L.p. | Buy | 5 714 285 | Pre- Funded Warrants (Right to Buy) |
2024-05-12 | Ra Capital Management, L.p. | Sell | 900 000 | Common Stock |
2024-03-07 | Gall Matthew | Buy | 163 200 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
76.67 |
Last 98 transactions |
Buy: 11 809 952 | Sell: 4 126 950 |
Volume Correlation
iTeos Therapeutics, Inc. Correlation
10 Most Negative Correlations | |
---|---|
SPT | -0.843 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
iTeos Therapeutics, Inc. Correlation - Currency/Commodity
iTeos Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $12.60M |
Gross Profit: | $11.70M (92.87 %) |
EPS: | $-3.15 |
FY | 2023 |
Revenue: | $12.60M |
Gross Profit: | $11.70M (92.87 %) |
EPS: | $-3.15 |
FY | 2022 |
Revenue: | $267.63M |
Gross Profit: | $266.82M (99.70 %) |
EPS: | $2.72 |
FY | 2021 |
Revenue: | $344 775 |
Gross Profit: | $344 775 (100.00 %) |
EPS: | $0.00881 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
iTeos Therapeutics, Inc.
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators